Excluding patients with recurrences during the fiveyear follow-up period, those who had been treated here with bed rest and given no specific antirheumatic treatment or prophylaxis did as well during this five-year period as those in the Co-operative Trial and the recent series who were on prophylaxis. However, with recurrences the bed-rest non-protected group fared less well; recurrences were more common and many were worse after them.
Summary A series of patients with rheumatic fever have been treated, half with 12-week courses of cortisone and half with aspirin.
No difference was noted between the two treatment groups in the development or disappearance of significant murmurs during the stay in hospital, nor was there any difference between them at five-year follow-up.
The series has been compared with another comprising similar cases that were treated with six-week courses of A.C.T.H., cortisone, or aspirin in the U.K.-U.S. Co-operative Clinical Trial. No difference was apparent between them either in hospital or at five-year follow-up.
Thus prolonged (12 weeks) courses of cortisone or aspirin as used in the present series had no advantage over the shorter one used in the Co-operative Clinical Trial and cortisone had none over salicylate.
Excluding patients with recurrences during the fiveyear follow-up period, those who had been treated here with bed rest and given no specific antirheumatic treatment or prophylaxis did as well during this five-year period as those in the Co-operative Trial and the recent series who were on prophylaxis. However, with recurrences the bed-rest non-protected group fared less well; recurrences were more common and many were worse after them.
Prophylaxis is still, therefore, the most effective way we have of reducing the severity of residual heart disease, and there is as yet no evidence that steroid is of value in this regard. REFERENCES Bywaters, E. G. L., and Thomas, G. T. (1961) . Brit. med. J., 1, 1628.
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- (1960) . Ibid., 2, 1033. "The [Royal College of] Physicians' report on the relationship between smoking and lung cancer has had an appreciably greater initial impact on tobacco consumption than was generally supposed.
Several weeks after the report was released it was widely estimated that cigarette sales had fallen by about 10 per cent. But withdrawals of tobacco from bond for home consumption (which to all intents and purposes are the same as sales to the public in normal times) fell by over 18 per cent in April, the first full month after the report was issued. The precise figures were 17,122,000 lb. in April this year compared with 21,155,000 lb. in April, 1961 . Prior to the report, withdrawals were only slightly less than those for a year earlier.
Thus it is fair to assume that virtually all of the April drop was directly attributable to the Physicians' report and the publicity it received, though part of it may have reflected a runnning down of stocks on retailers' shelves. Recent statements from the trade indicate that the public has already recovered from the shock.
Estimates now suggest that cigarette consumption is now no more than 5 per cent. below last year's levels and may be almost back to them. Thus if this is true the pattern of demand has been similar to that which usually follows an increase in tobacco duty." In recent years there has been a decline in the incidence of rheumatic fever (Brit. med. J., 1959), and this fall has been accentuated since antibiotics became generally available for the treatment of throat infections. There is also an impression that the illness is less severe now than it was in the past and that the immediate mortality is less (Royal College of Physicians, 1957) . Some recent studies of rheumatic fever have been concerned with children (Massell, 1958; Co-operative Clinical Trial, 1960; Bywaters and Thomas, 1961) or predominantly with young males in the British or American armed Forces (Slater and Rosenbaum, 1959; Malpas and Landon, 1960; Gray, 1949; Carmichael, 1956; Bates, 1958) .
The present paper reports on the incidence, clinical picture, and response to treatment of rheumatic fever in adolescents and adults admitted in the past seven years to this unit.
Clinical Materl and Investigations
During the period between March, 1954, and February, 1961, 139 patients over 12 years of age satisfied the diagnostic criteria for acute rheumatic fever. These were essentially those of Jones (1944) 5. A reliable history of rheumatic fever, as defined in these criteria, or evidence of pre-existing rheumatic heart disease-During the same period of time 140 other patients were investigated for rheumatic fever and did not satisfy these rigid criteria, although 58 of this group were thought to have subacute or acute rheumatism (Table I) . In addition to the history and regular clinical examination, the E.S.R. was estimated on admission and at intervals of one week or less, chest x-ray films were taken periodically, and E.C.G.s were recorded at least weekly. Throat swabs were taken for bacteriological study from each patient on at least one occasion, and the antistreptolysin 0 titre was estimated in some of the later patients. of the patients were in the 12-19 years age-group; the three oldest were 50, 58, and 60 years of age. The seasonal variation in the incidence of the disease was analysed by calculating the monthly fluctuations from the trend*; the result is shown in the Chart. January, and to a lesser degree December, tended to have more cases than average and July and August less than average. *Twelve-monthly moving totals of patients were calculated each adjacent pair of totals was summated and this figure was divided by 24 to obtain the " trend " for a given month-that is, for the central month of a 13-month group. The variation between this number and the number of patients actually admitted in that month is the " fluctuation from the trend " and reflects only seasonal influences. The Chart shows the averages for the seven years. Any tendeacy for an increase or decrease in incidence over the years is cancelled out. 
Family and Previous History
Only 11 (8%) of the 139 patients gave a history of acute rheumatism or rheumatic heart disease in close relatives. (In contrast, 20 out of the 21 children treated during the same period had a positive family history.)
A previous attack of acute rheumatism or chorea was reported in 54 (39%) of the patients; 50 had had rheumatic fever, three had had chorea, and one had had arthritis and chorea together. Table III gives details of the number of previous attacks and of the age at which the patient first developed acute rheumatism. Of these 54 patients, 46 (85%) had their first attack before the age of 20. a change in heart size exceeding 15% ; a further four had pericardial friction or effusion as the only evidence of carditis (Table IV) . The location, timing, and intensity of the cardiac murmurs that were present on admission or developed in the acute attack are listed in Table V. Using the classification adopted in the combined U.K.-U.S.A. trial (Co-operative Clinical Trial, 1955) , 94 (67%) of the present series were in group A (no definite carditis and no pre-existing heart disease), 22 (16%) were in group B (carditis in those with no pre-existing rheumatic heart disease), and 23 (17%) in group C (definite or questionable pre-existing rheumatic heart disease).
Erythema marginatum occurred in 7 patients (5%) and subcutaneous nodules in only one patient. Twentyfive patients satisfied two or more major criteria.
Minor Criteria All but one patient had an elevated E.S.R., 112 (81 %) had significant fever, as defined in the minor criteria, and 114 (82%) had definite or presumptive evidence of streptococcal infection. On the electrocardiogram 48 (35%) had heart-block of some degree or atrioventricular dissociation. Pre-existing rheumatic heart disease was noted in 23 patients (17%).
A history of sore throat and fever in the four weeks prior to the onset of rheumatic symptoms was obtained from 97 patients (70%). This was the only evidence of streptococcal infection in 62 cases. Beta-haemolytic streptococci were grown in significant numbers from the throat swabs of 47 patients (33%). (Many of the patients had received penicillin or another antibiotic before admission to hospital.) Ten patients had /3-haemolytic streptococci grown from their throat despite the absence of any recent sore throat.
The most common form of heart-block was firstdegree (potential) heart-block; the P-R interval reached 0.22 second in 34 cases and 0.20 second in another 12. Two had partial heart-block of the Wenckebach type and 10 had complete heart-block or atrio-ventricular dissociation, often complicated by interference by beats arising in or near the A-V node.
Of the 23 patients with pre-existing rheumatic heart disease, 8 had mitral incompetence on admission, 16 had mitral stenosis, and 11 had aortic incompetence, either as isolated lesions or in combination. The various combinations are listed in Table VI , and it will be seen that isolated mitral stenosis was the commonest lesion. Course of the Illness Ninety-one patients (65%) had reached hospital within one week of the onset of rheumatic symptoms and another 17 in the second week, giving a total of 108 (78%) arriving within 14 days.
The fever and joint pains had both settled within 48 hours of admission in 20 cases and within seven days in a total of 116 (83%) ( Table VIII) . Only one patient had neither joint pain nor fever, having presented with chorea. Seventy-three patients (53 %) had abnormalities of the E.C.G. which were attributed to the acute rheumatic process. In 54 cases (39 %) these abnormalities consisted of various degrees of heart-block (complete block in 11 cases, partial block in 2 cases, prolongation of P-R to 0.22 second or more in 36 cases and to 0.20 or 0.21 second in 15 cases); the remaining 19 patients had other E.C.G. abnormalities such as prolongation of the Q-T, interval, ST-T changes, and arrhythmias. These E.C.G. abnormalities resolved in one week or less in 22 cases, in two weeks in another 14, and in three weeks in another 9. In a total of 48 patients (66% of those who had E.C.G. abnormalities) the signs resolved within four weeks (Table IX) . In 15 patients the E.C.G. abnormalities persisted for more than 12 weeks; 14 of these were male and only one female, and this sex difference is significant (X2 = 4.76, P<0.05).
When salicylate dosage was reduced or discontinued 23 patients (17%) developed symptoms or signs of relapse such as arthralgia, arthritis, fever, or secondary elevation of the E.S.R., and in all but two cases these settled either spontaneously or with further salicylate therapy within a few days. and found that no conclusion could be drawn, since reports were contradictory.
The incidence of the disease in this series is lowest in midsummer (July) and highest in midwinter (January), but if statistical analysis is applied to the incidence by months, only January (with 24 cases) is found to have a significant excess of cases above the mean (mean +2 S.D. =11.6+ 10.7), and no month has a significant reduction from the mean. No group of three months has either significantly more or significantly less than the average. The seasonal incidence of rheumatic fever closely follows that of streptococcal infection and is usually found to be highest in spring and lowest in autumn (Jones and Bland, 1952) , but a more recent study by Hitchens (1958) in this country does not present such a clear-cut division into an epidemic and a sporadic season. For many years there has been a clinical impression that the morbidity and mortality from rheumatic fever have been declining steadily. According to Jones and Bland (1952) , in the U.S.A. this decrease probably dates from the turn of the century and clearly antedates the introduction of chemotherapeutic and antibiotic agents. Certainly in recent years it has become accepted both in the U.S.A. (Bates, 1958) and in Britain (Bywaters and Thomas, 1961 ) that rheumatic fever is a milder disease.
In the large series of 498 children studied in the U.S.A.
and Britain in 1951 -2 (Co-operative Clinical Trial, 1960 there was only one death in the acute illness. The present series reflects the same trend: there were no deaths in the acute illness, and only two patients had the prolonged hectic fever, persistent arthritis, and multiple complications which were a feature of rheumatic fever some years ago; some of these old cases may in fact have had systemic lupus erythematosus. There is nothing to suggest that the 21 children treated during the same period as this series had a more severe or prolonged illness than the adolescents and adults. In most respects the patterns of their disease closely followed that of the 139 adolescents and adults. The routine treatment, which comprised bed rest and salicylates, followed with penicillin after a few days, was sufficient to control acute symptoms and signs in all but the two patients whose details are given, and who required corticosteroid therapy to control their illness. Rheumatic activity, as measured by the E.S.R., lasted no longer than four weeks in 92 (66%) of the patients.
The incidence of carditis in this series (18%) is much lower than is usually recorded. (This figure is based on the specifications given in the list of major criteria.) Jones and Bland (1952) It is suggested that a fairly mild form of rheumatic fever is being seen nowadays, at least in adolescents and adults, but the continued high incidence of cardiac involvement re-emphasizes the need for careful treatment and for prophylaxis against recurrences.
This work was carried out while the unit was under the direction of the late Dr. James Reid. We thank Professor E. J. Wayne for his assistance in the preparation of this paper.
